BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 20923954)

  • 21. Total lymphocyte count is a reliable surrogate marker for CD4 cell counts after the first year of antiretroviral therapy: data from an Indonesian cohort study.
    de Jong MA; Wisaksana R; Meijerink H; Indrati A; van de Ven AJ; Alisjahbana B; van Crevel R
    Trop Med Int Health; 2012 May; 17(5):581-3. PubMed ID: 22364582
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CD4 percentages and total lymphocyte counts as early surrogate markers for pediatric HIV-1 infection in resource-limited settings.
    Rouet F; Inwoley A; Ekouevi DK; Viho I; Becquet R; Sakarovitch C; Bequet L; Tonwe-Gold B; Chaix ML; Leroy V; Rouzioux C; Dabis F;
    J Trop Pediatr; 2006 Oct; 52(5):346-54. PubMed ID: 16782723
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predicting CD4 count using total lymphocyte count: a sustainable tool for clinical decisions during HAART use.
    Mwamburi DM; Ghosh M; Fauntleroy J; Gorbach SL; Wanke CA
    Am J Trop Med Hyg; 2005 Jul; 73(1):58-62. PubMed ID: 16014833
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence of anemia and correlation with biomarkers and specific antiretroviral regimens in 9690 human-immunodeficiency-virus-infected patients: findings of the Anemia Prevalence Study.
    Mildvan D; Creagh T; Leitz G;
    Curr Med Res Opin; 2007 Feb; 23(2):343-55. PubMed ID: 17288689
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of CD4 counts and percentages in the HIV infected Indian population.
    Vajpayee M; Kanswal S; Wig N; Seth P
    Southeast Asian J Trop Med Public Health; 2004 Mar; 35(1):144-6. PubMed ID: 15272758
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term follow-up of asymptomatic HIV-infected patients who discontinued antiretroviral therapy.
    Fernández Guerrero ML; Rivas P; Molina M; Garcia R; De Górgolas M
    Clin Infect Dis; 2005 Aug; 41(3):390-4. PubMed ID: 16007538
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of hepatitis C virus (HCV) viremia and HCV genotype in the immune recovery from highly active antiretroviral therapy in a cohort of antiretroviral-naive HIV-infected individuals.
    Antonucci G; Girardi E; Cozzi-Lepri A; Capobianchi MR; De Luca A; Puoti M; Petrelli E; Carnevale G; Rizzardini G; Grossi PA; Viganò P; Moioli MC; Carletti F; Solmone M; Ippolito G; Monforte AD; ;
    Clin Infect Dis; 2005 Jun; 40(12):e101-9. PubMed ID: 15909251
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Survival and immune response of rural HIV/AIDS patients after free antiretroviral therapy].
    Ding YY; Jia WQ; Wang JS; Dong SL; Yang QH; Zhou RY; Qu SX; Lu LX; Wei J; Qiao XC; Gao MY; Guo XL; Zhang TJ; Wu ZY; He N
    Zhonghua Liu Xing Bing Xue Za Zhi; 2008 Dec; 29(12):1176-80. PubMed ID: 19173958
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Total lymphocyte count and hemoglobin combined in an algorithm to initiate the use of highly active antiretroviral therapy in resource-limited settings.
    Spacek LA; Griswold M; Quinn TC; Moore RD
    AIDS; 2003 Jun; 17(9):1311-7. PubMed ID: 12799552
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interruption of antiretroviral treatment in HIV-infected patients with preserved immune function is associated with a low rate of clinical progression: a prospective study by AIDS Clinical Trials Group 5170.
    Skiest DJ; Su Z; Havlir DV; Robertson KR; Coombs RW; Cain P; Peterson T; Krambrink A; Jahed N; McMahon D; Margolis DM;
    J Infect Dis; 2007 May; 195(10):1426-36. PubMed ID: 17436222
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy and safety of indinavir/ritonavir 400/100 mg twice daily plus two nucleoside analogues in treatment-naive HIV-1-infected patients with CD4+ T-cell counts <200 cells/mm3: 96-week outcomes.
    Mootsikapun P; Chetchotisakd P; Anunnatsiri S; Boonyaprawit P
    Antivir Ther; 2005; 10(8):911-6. PubMed ID: 16430196
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quality control of the total lymphocyte count parameter obtained from routine haematology analyzers, and its relevance in HIV management.
    Marshall S; Sippy N; Broome H; Abayomi A
    Afr J Med Med Sci; 2006 Jun; 35(2):161-3. PubMed ID: 17209312
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CD4+ cell count, viral load, and highly active antiretroviral therapy use are independent predictors of body composition alterations in HIV-infected adults: a longitudinal study.
    McDermott AY; Terrin N; Wanke C; Skinner S; Tchetgen E; Shevitz AH
    Clin Infect Dis; 2005 Dec; 41(11):1662-70. PubMed ID: 16267741
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Susceptibility to opportunistic infections in HIV-infected patients with increased CD4 T-cell counts on antiretroviral therapy may be predicted by markers of dysfunctional effector memory CD4 T cells and B cells.
    French M; Keane N; McKinnon E; Phung S; Price P
    HIV Med; 2007 Apr; 8(3):148-55. PubMed ID: 17461858
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Absolute lymphocyte count: a cost-effective method of monitoring HIV-infected individuals.
    Kakar A; Beri R; Gogia A; Byotra SP; Prakash V; Kumar S; Bhargava M
    Indian J Pathol Microbiol; 2011; 54(1):107-11. PubMed ID: 21393889
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reliability of absolute lymphocyte count as a marker to assess the need to initiate antiretroviral therapy in HIV-infected children.
    Shah I; Parikh S
    J Postgrad Med; 2012; 58(3):176-9. PubMed ID: 23023348
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CD4 counts in laboratory monitoring of HIV disease--experience from western India.
    Ingole N; Nataraj G; Mehta P; Paranjpe S; Sarkate P
    J Int Assoc Provid AIDS Care; 2014; 13(4):324-7. PubMed ID: 23442562
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Total Lymphocyte Count and Haemoglobin Concentration Combined as a Surrogate Marker for Initiating Highly Active Antiretroviral Therapy in a Resource-limited Setting as against CD4 Cell Count.
    Dhamangaonkar AC; Mathew A; Pazare AR
    West Indian Med J; 2014 Sep; 63(5):460-4. PubMed ID: 25781283
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CD4 counts in laboratory monitoring of HIV disease--experience from western India.
    Ingole N; Nataraj G; Mehta P; Paranjpe S; Sarkate P
    J Int Assoc Provid AIDS Care; 2014; 13(4):324-7. PubMed ID: 25513028
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Correlation analysis on total lymphocyte count and CD4 count in HIV-infected patients: a retrospective evaluation.
    Wang Y; Liang S; Yu E; Guo J; Li Z; Wang Z; Du Y
    J Huazhong Univ Sci Technolog Med Sci; 2011 Oct; 31(5):712. PubMed ID: 22038367
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.